Patent application number | Description | Published |
20080227831 | FOOD EXTRACTS FOR TREATMENT OF LIPOPROTEIN ABNORMALITIES AND SKIN DISEASES AND SKIN DISORDERS - The present invention is directed to N-methylnicotinamide containing food extracts, and their use in treating lipoprotein abnormalities and skin diseases and disorders. | 09-18-2008 |
20090016956 | Labeled Macrophages and Methods of Use Thereof - Methods of making and using labeled macrophages are described. | 01-15-2009 |
20090252704 | THERAPIES FOR COGNITION AND LEARNING ENHANCEMENT - The invention relates to a combination comprising an amount of an NO donor, such as ISDN, and/or an amount of another pharmaceutical agent that enhances neurotransmission or which acts as neuroprotectants such as memantine, clomethiazole and tacrine. These compositions can be used in producing cognition and learning enhancement, whereby the invention also provides for a new method of treatment of Alzheimer's disease and related neurodegenerative disorders. | 10-08-2009 |
20100120726 | 1-Methylnicotinamide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities - The present invention is directed to nicotinamide derivatives, and their use in treating lipoprotein abnormalities, alone or in combination with a statin. | 05-13-2010 |
20100221247 | AGENTS AND METHODS FOR TREATMENT OF CANCER - The present application describes compositions that are useful for the treatment, prevention and/or amelioration of cancer. | 09-02-2010 |
20110096157 | MICROSCOPY IMAGING - Among other things, an imaging device has a photosensitive array of pixels, and a surface associated with the array is configured to receive a specimen with at least a part of the specimen at a distance from the surface equivalent to less than about half of an average width of the pixels. | 04-28-2011 |
20120245115 | 1-Methylnicotinaide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities - The present invention is directed to nicotinamide derivatives, and their use in treating lipoprotein abnormalities, alone or in combination with a statin. | 09-27-2012 |
20130245078 | SALT COMPOUND - A salt compound, and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject using the salt compound are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic salt compound comprising a nitrate ester. | 09-19-2013 |
20130281888 | TASK-ASSOCIATED MOTION ANALYSIS - Systems and methods for task-associated motion analysis are provided. In the task-associated motion analysis system, a protocol including one or more motion-based tasks is performed by a patient. The patient's performance is recorded using one or more sensors and the patient's data is compared to normative data to assess musculoskeletal performance for the purposes of diagnosis and administration of therapy or training recommendations. | 10-24-2013 |
20130303860 | SYSTEMS AND METHODS FOR USE IN FALL RISK ASSESSMENT - Systems and methods for use in patient fall risk assessment are provided. In the fall risk assessment system, a Protocol including one or more motion-based tests is performed by a patient. The patient's performance is recorded using one or more sensors and the patient's data is compared to normative data to assess risk within the multifactorial problem of fall risk assessment and management. | 11-14-2013 |